Followers | 150 |
Posts | 9,319 |
Boards Moderated | 7 |
Alias Born | 03/29/2017 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yup .
Yup, something is up. Those warrants paint a pretty picture, as does the merger article like you have spoken on brother.
On June 28, 2017, the Company executed an Asset Assignment Agreement (“Asset Assignment Agreement”) with Richard L. Chang Holding’s LLC (“Holdings LLC”), pursuant to which Holdings was issued 60,000,000 shares of the Company’s common stock and 2,000,000 restricted, non-convertible, non-dividend paying shares of the Company’s preferred stock with 1000 to 1 voting rights over shares of the Company’s common stock. In consideration of these share issuances, Holdings LLC has assigned to the Company all of its rights, title and interest in United States Utility Patent Application No. 62/420,177 filed on November 10, 2016, titled “ COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF PARKINSON’S DISEASE” and all related intellectual property, inventions and trade secrets, data, and clinical study results. Additionally, the Company issued 15,000,000 common shares to Rich Pharmaceuticals, Inc. for use of the clinical trial under an Investigational New Drug Application. The Asset Assignment Agreement grants to Holdings LLC the right to require the Company to assign back to Holdings LLC the Patent Application and all related intellectual property in the even the Company does not raise a minimum of $1,000,000 in equity financing by June 28, 2018 . In the event that Holdings LLC exercises this right of reversion, the 2,000,000 shares of Preferred Stock issued to Holdings LLC shall be assigned to Apica Investments Limited or its assignees. The common and preferred shares were valued at $77,000. Further cash compensation was given in the amount of $100,000 totaling an investment of $177,000.
Quote:
Pursuant to the June 28, 2017 Asset Assignment Agreement with Holdings LLC and its assignment to the Company all of its rights, title and interest in United States Utility Patent Application No. 62/420,177 filed on November 10, 2016, titled “ COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF PARKINSON’S DISEASE” and all related intellectual property, inventions and trade secrets, data, and clinical study results there is a major fund raising requirement. The Company must raise a minimum of $1,000,000 in equity financing by June 28, 2018. The Asset Assignment Agreement grants to Holdings LCC the right to require the Company to assign back to Holdings LLC the Patent Application and all related intellectual property in the event the Company does not raise a minimum of $1,000,000 in equity financing by June 28, 2018 . In the event that Holdings LLC exercises this right of reversion, the 2,000,000 shares of Preferred Stock issued to Holdings LLC shall be assigned to Apica Investments Limited or its assignees. As of August 31, 2017, the Company has not raised any capital towards the $1,000,000 requirement.
Item 1. Description of Registrant’s Securities to be Registered.
The description of securities contained in Registrant’s Registration Statement on Form S-1, as amended, filed with the commission (File No. 333-207383) is incorporated by reference into this registration statement.
Item 2. Exhibits
Exhibit No.
Description of Exhibit
Exhibit 2.1
Asset Assignment Agreement(4)
Exhibit 3.1
Articles of Incorporation of the Registrant (1)
Exhibit 3.2
Bylaws of the Registrant (1)
Exhibit 3.3
Certificate of Amendment(3)
Exhibit 3.4
Certificate of Amendment(3)
Exhibit 3.5
Certificate of Amendment(7)
Exhibit 3.6
Articles of Merger(6)
Exhibit 3.7
Certificate of Amendment(6)
Exhibit 4.1
Amendment to Promissory Note(4)
Exhibit 4.2
Promissory Convertible Note(4)
Exhibit 4.3
Common Stock Purchase Warrant(4)
Exhibit 4.4
Common Stock Purchase Warrant(4)
Exhibit 4.5
Common Stock Purchase Warrant(4)
Exhibit 4.6
Common Stock Purchase Warrant(4)
Exhibit 4.7
Common Stock Purchase Warrant(4)
Exhibit 4.8
Common Stock Purchase Warrant(4)
Exhibit 10.1
Marketing and Sales Distribution Agreement(1)
Exhibit 10.2
Marketing and Sales Distribution Agreement(2)
Exhibit 10.3
Marketing and Sales Distribution Agreement(2)
Exhibit 10.4
Marketing and Sales Distribution Agreement(2)
Exhibit 10.5
Marketing and Sales Distribution Agreement(2)
Exhibit 10.6
Consulting Agreement(4)
Exhibit 10.7
Consulting Agreement(4)
Exhibit 10.8
Employment Agreement(5)
Exhibit 10.9
Consulting Agreement(5)
Exhibit 10.10
Support and Collaboration Agreement(5)
Can confirm OS. Waiting on filings 2 come out so I can try 2 get an address 4 this construction. Float SUPER TIGHT. Wish they would redesign the website 4 homes, looks like a third graders school project.
Investor Relations <Info@auscretehomes.com>
Nov 15 (1 day ago)
to me
Float 15.5 MM, looks to remain small & tight
Issued 220 MM with 204MM Restricted
Regards,
Investor Relations
#3 on Breakout Boards. Volume still low @ 9m. $TGRR tiger shark is loose!
You have link showing no current employees? I checked last filing and didn't see any info but OTCmarkets says 6. The dilution is 2 pay 4 movie production. It is all open 4 the world 2 see. Cool name BRO.
M_Ms
Followed By
0
Posts
1
Boards Moderated
0
Alias Born
11/16/17
Financial Reporting/Disclosure
Reporting Status
Alternative Reporting Standard
Deregistered a/o Feb 12, 2010
Audited Financials
Unaudited
Latest Report
Jul 31, 2017 Quarterly Report
CIK
0001109067
Fiscal Year End
10/31
OTC Marketplace
Pink Current
Profile Data
SIC - Industry Classification
7812 - Motion picture and video production
Incorporated In:
DE, USA
Year of Inc.
1961
Employees
6 a/o Mar 08, 2016
Company Officers/Contacts
Gordon Scott Venters
President, CEO, Acting CFO
Yo X, why you say scam? Richard Chang has patents he sold 2 HPGN and Ben Chang did much work for HPGN. RCHA should be popping news soon I think bro.
Hard 2 say bro. RCHA should be trading much higher even without merger news imo, just the funding is terrible here like always. I would think if news came out pertaining 2 merger it would easily get back 2 your buy in area.
IMO, RCHA not diluting anymore could mean a lot. Maybe that equity financing that HPGN had to raise was meant for something. HPGN filed a 8-A12G end of October. Had some stock warrants and article of merger. Link is on bottom.
On June 28, 2017, the Company executed an Asset Assignment Agreement (“Asset Assignment Agreement”) with Richard L. Chang Holding’s LLC (“Holdings LLC”), pursuant to which Holdings was issued 60,000,000 shares of the Company’s common stock and 2,000,000 restricted, non-convertible, non-dividend paying shares of the Company’s preferred stock with 1000 to 1 voting rights over shares of the Company’s common stock. In consideration of these share issuances, Holdings LLC has assigned to the Company all of its rights, title and interest in United States Utility Patent Application No. 62/420,177 filed on November 10, 2016, titled “ COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF PARKINSON’S DISEASE” and all related intellectual property, inventions and trade secrets, data, and clinical study results. Additionally, the Company issued 15,000,000 common shares to Rich Pharmaceuticals, Inc. for use of the clinical trial under an Investigational New Drug Application. The Asset Assignment Agreement grants to Holdings LLC the right to require the Company to assign back to Holdings LLC the Patent Application and all related intellectual property in the even the Company does not raise a minimum of $1,000,000 in equity financing by June 28, 2018 . In the event that Holdings LLC exercises this right of reversion, the 2,000,000 shares of Preferred Stock issued to Holdings LLC shall be assigned to Apica Investments Limited or its assignees. The common and preferred shares were valued at $77,000. Further cash compensation was given in the amount of $100,000 totaling an investment of $177,000.
Pursuant to the June 28, 2017 Asset Assignment Agreement with Holdings LLC and its assignment to the Company all of its rights, title and interest in United States Utility Patent Application No. 62/420,177 filed on November 10, 2016, titled “ COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF PARKINSON’S DISEASE” and all related intellectual property, inventions and trade secrets, data, and clinical study results there is a major fund raising requirement. The Company must raise a minimum of $1,000,000 in equity financing by June 28, 2018. The Asset Assignment Agreement grants to Holdings LCC the right to require the Company to assign back to Holdings LLC the Patent Application and all related intellectual property in the event the Company does not raise a minimum of $1,000,000 in equity financing by June 28, 2018 . In the event that Holdings LLC exercises this right of reversion, the 2,000,000 shares of Preferred Stock issued to Holdings LLC shall be assigned to Apica Investments Limited or its assignees. As of August 31, 2017, the Company has not raised any capital towards the $1,000,000 requirement.
29 Million volume, #8 on breakout boards. $TGRR machine is churning. Party pooper @ 13s with 1.6m bid lol. VNDM @ half a penny, BMIC hanging around tho.
Float is 500k(as of sept 2017) but no trades for awhile. Lot of info about the 2 out there.. CEO of HPGN was on board @ RCHA. Richard Chang is on board @ HPGN and Ben Chang does work 4 them. Both Changs own shares in HPGN.
HPGN majority vote is controlled by Richard Chang also.
Thought this was 7th quarter .
VNDM @ .006 so us breaking .006s I doubt. If news was put out, I think we could get him 2 move... Just replyin..
All up 2 Lord VNDM.. New filing should show how much they owe in notes but float is crazy here.
They just bought that land in August, no PR on it besides the 8k I think. Think they would put out a PR soon 4 eyes.
On August 18, 2017, Auscrete Corporation ("company") announced that it had signed an agreement with the City of Goldendale, WA. for the purchase of a total of 10 acres of land on the Goldendale Industrial Estate. The agreement is in 2 parts. The first part is the purchase of 2 x 2.5 acre lots, being a total of 5 acres at $20,000 per acre for an overall cost of $100,000. This portion of land is to be used for setting up the company's initial manufacturing plant. The foremost production building comprises of a 25,000 sq. ft. structure and there will be a 15,000 sq. ft. supply and manufacturing support building.
The second part is the purchase of an additional 2 x 2.5 acre lots for a total of 5 acres that abuts to the first lots to form a square 10 acre site. These second 5 acres are under option and the company has 12 months to finalize this purchase. The cost of this property will be $25,000 per acre for a total purchase price of $125,000.
Yeah, this price=easy returns. A lot going on between RCHA and HPGN so have good chance of news pertaining 2 both from either of them hopefully.
Nice bro.. They deserve it. Company has been very forthright about debt etc in conversations with me.
After IRMA destruction, now the debt holders are grinding the heel 2 the neck. BS
4 sure Beer. $RCHA is an easy hold 4 me. Next news will be mega I believe. GL 2 us all here.
Technically we did have news last business quarter, this was released in July.
http://www.richpharmaceuticals.com/wp-content/uploads/2017/08/PR-Rich-Pharmaceuticals-Announces-Consulting-Agreement-FINAL.pdf
If we don't see news by this time next month you have a point.
4 sure CAYO. @ this level your gonna make a killing when it starts. Great company here.
$ABBY unbelievable float of 30 Million. In the midst of acquiring Auto Dealership in California.. Closed @ .0045..
52-Wk Range
0.0011 - 0.018
Per second quarterly below..
We have identified what we believe to be an opportunity in the auto industry to disrupt and change the way the consumer performs the task of purchasing vehicles. The company continues to fulfill the definitive agreement between Abby and The Evans Corporation.
Abby Inc. continues to invest to become the majority stake holder of The Evans Corporation. During our fiscal 3rd quarter Abby was issued stock in The Evans Corporation and has included them in their financials. The Evans Corporation is an Automotive Auto Broker that focuses on Auto Brokerage and Sales doing business in California under Evans Auto Brokerage & Sales.
The 89,416,670 shares of our common stock are restricted in accordance with Rule 144.
The 30,341,701 shares of our common stock are free of all restrictions to
trading in accordance to Rule 144.
$ABBY Super low float of 30 Million. Legit business operations in midst of acquiring Auto Dealership.
Per second quarterly below..
We have identified what we believe to be an opportunity in the auto industry to disrupt and change the way the consumer performs the task of purchasing vehicles. The company continues to fulfill the definitive agreement between Abby and The Evans Corporation.
Abby Inc. continues to invest to become the majority stake holder of The Evans Corporation. During our fiscal 3rd quarter Abby was issued stock in The Evans Corporation and has included them in their financials. The Evans Corporation is an Automotive Auto Broker that focuses on Auto Brokerage and Sales doing business in California under Evans Auto Brokerage & Sales.
The 89,416,670 shares of our common stock are restricted in accordance with Rule 144.
The 30,341,701 shares of our common stock are free of all restrictions to
trading in accordance to Rule 144.
$ABBY Super low float of 30 Million. Legit business operations in midst of acquiring Auto Dealership.
Per second quarterly below..
We have identified what we believe to be an opportunity in the auto industry to disrupt and change the way the consumer performs the task of purchasing vehicles. The company continues to fulfill the definitive agreement between Abby and The Evans Corporation.
Abby Inc. continues to invest to become the majority stake holder of The Evans Corporation. During our fiscal 3rd quarter Abby was issued stock in The Evans Corporation and has included them in their financials. The Evans Corporation is an Automotive Auto Broker that focuses on Auto Brokerage and Sales doing business in California under Evans Auto Brokerage & Sales.
The 89,416,670 shares of our common stock are restricted in accordance with Rule 144.
The 30,341,701 shares of our common stock are free of all restrictions to
trading in accordance to Rule 144.
ABBY should see quarter 3 filings today or tomorrow. 45 days past End of Quarter to post unless you file an extension. End of Sept is quarter 3. Filings are always a good chance 2 get a little more info on things that are cooking. Good luck DJ.
Filings will shed some light... They just filed 10-q so little wait. Im thinking they'd wanna get this going fast since handing over 100k and waiting is no bueno.
Will check it out regardless when I get more info. So close 2 home haha.
Haha man possessed. Mr. MVES.
Crazy float.. You know if new plant is already under construction? I am few hours away. might visit the place. Great drive 2 get there.
On August 18, 2017, Auscrete Corporation ("company") announced that it had signed an agreement with the City of Goldendale, WA. for the purchase of a total of 10 acres of land on the Goldendale Industrial Estate. The agreement is in 2 parts. The first part is the purchase of 2 x 2.5 acre lots, being a total of 5 acres at $20,000 per acre for an overall cost of $100,000. This portion of land is to be used for setting up the company's initial manufacturing plant. The foremost production building comprises of a 25,000 sq. ft. structure and there will be a 15,000 sq. ft. supply and manufacturing support building.
Dont know brother. New filing should be coming tonight or at least extension. I am just looking around, do not hold this yet.
1. For each Fiscal Quarter End, upload a Quarterly Report via www.OTCIQ.com within 45 days of the quarter end. (A separate quarterly report is not required for the 4th quarter.) The Quarterly Report should include:
? Information in accordance with these OTC Pink Basic Disclosure Guidelines -- use the fillable form beginning on page 3.
? Quarterly financial statements (Balance Sheet, Income Statement, Statement of Cash Flows, Notes to Financial Statements).
? No Audit Letter or Attorney Letter is required.
I copied and paste from otc page, float is emtpy. Filings shows what float is from last quarter... It all jives math wise, so whats up? I do not need to confirm what I confirmed myself.
For float? Was on filings. Here ya go bro.
https://www.otcmarkets.com/financialReportViewer?symbol=ABBY&id=177837
Those rev numbers are crazy. If they work on cutting fat or just luck goes their way and line up some juicy government work etc, good entry here imo, but I can see a Q coming by this ticker lol.
We have identified what we believe to be an opportunity in the auto industry to disrupt and change the way the consumer performs the task of purchasing vehicles. The company continues to fulfill the definitive agreement between Abby and The Evans Corporation.
Abby Inc. continues to invest to become the majority stake holder of The Evans Corporation. During our fiscal 3rd quarter Abby was issued stock in The Evans Corporation and has included them in their financials. The Evans Corporation is an Automotive Auto Broker that focuses on Auto Brokerage and Sales doing business in California under Evans Auto Brokerage & Sales.
https://www.evansautobrokerage.com/
Market Value1 $538,913 a/o Nov 13, 2017
Authorized Shares 500,000,000 a/o Oct 13, 2017
Outstanding Shares 119,758,371 a/o Oct 13, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 30,341,701
Par Value 0.001
The 89,416,670 shares of our common stock are restricted in accordance with Rule 144.
The 30,341,701 shares of our common stock are free of all restrictions to
trading in accordance to Rule 144.
Same wit me. Pinks with all smoke and mirrors trade higher.. Movies available streaming, app in works with webpage already up. Just straight cheapies 2 load on until eyes come.
When I cannot find OS I just divide available market cap by PPS. I get 246,918,666.
Market cap updated yesterday on OTC page.
Market Value1 $185,189 a/o Nov 13, 2017
Authorized Shares 500,000,000 a/o Oct 19, 2016
Outstanding Shares 205,765,428 a/o Jun 07, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 6,995,307 a/o Oct 19, 2016
Par Value 0.001
185,189/.00075= 246,918,666
Ive always done this, could be in error tho..
4 sure lukin. We get PR or some hvy eyes/buys we are golden.
Lets get this going people.. Gotta AMP it up.
IMD Companies, Inc. (OTC: ICBU) Board of Directors announced today that the company's subsidiary KRSNA Minerals had record revenues of $4,616,013 and net profits of $996,490 for the second quarter June 30, 2017. The company expects higher revenue numbers for the third quarter as well. iMD filed its second quarter financials today and expects to have third quarter financials filed by the end of next week. The company expects to be fully current with OTC Markets next week as well. The company will announce Third Quarter Financials once filed.
KRSNA Minerals is expanding operations on its mines because of additional purchase orders from Hong Kong based company for 5,000 Metric Tons of Magnesia Chrome Powder and 40,000 Metric Tons of Iron Ore increasing the purchase order to approximately 70 million dollars. Because of the additional orders the contract had to be extended to two years for delivery. The company is looking to ship its second order of 10,000 metric tons of Chrome Powder as first order was shipped last quarter. Mining Operations are moving forward on all orders.
$MVES TIGHT SS, Major Catalysts Coming Soon.
134 MILLION FLOAT!!!!!!!!!!!!!!!
Near 52 week low
52-Wk Range
0.002 - 0.013
Price
$0.0023
Market Value1
$534,256
a/o Nov 10th, 2017
Authorized Shares
750,000,000
a/o Nov 1st, 2017
Outstanding Shares
378,609,979
a/o Nov 1st, 2017
-Restricted
243,987,853
-Unrestricted
Not Available
Held at DTC
Not Available
Float
134,622,126
a/o Nov 1st, 2017
HALLANDALE BEACH, Fla., Oct. 19, 2017 (GLOBE NEWSWIRE) -- The Movie Studio, Inc. (OTC:MVES) (the "Company") www.TheMovieStudio.com is a vertically integrated motion picture production and distribution company motion pictures, production and distribution assets.
The Movie Studio is pleased to announce that it has successfully negotiated a content license and revenue participation agreement with Lotus Research, Inc. for the Vu-Me on-line content aggregation and application platform. The Movie Studio and Vu-Me App Platform intend to implement an on-line platform and dashboard for “The Movie Studio” with a subscription based credit card interface to access The Movie Studio library and “New Releases” of owned and licensed content available for Video on Demand (VOD) to monetize the content including a back end “bank” In addition to the VOD Platform, The Movie Studio intends to integrate in the acquisition of Emerging Pictures and all of its assets, including its proprietary intellectual property, which includes an innovative technology for a Commercial VOD (Video on Demand) digital delivery platform presently deployed in over 130 theaters, as well as digital distribution rights to potentially many hundreds of films. The technology can also be used to gauge consumer demand as well as provide advanced data analytics to match and deliver content. This enables providers and exhibitors to be more effective and advanced in their distribution tactics and have greater direct contact and feedback from their audiences. The network of over 130 theaters in which the VOD hardware is presently deployed spans 36 states in the U.S.
“With many competing apps available to consumers, Lotus Research opted to leap ahead of the technology wave with several important features,” noted Leo Pimentel. These features include: (1) low latency across WiFi and cellular networks; (2) 4K and HD streaming and playback; (3) a proprietary compression algorithm; (4) rapid share-ability across social networking sites and communication channels; (5) machine-learning algorithms to refine and enhance search and content relevance; and (6) effective content tracking across all platforms on and off Vu-Me for robust and accurate reporting and metrics gathering. Leo Pimentel, CEO & Founder, stated today.
About Lotus Research, Inc.: Lotus Research is headquartered in New York City and was founded by Leo Pimentel in 2014. With a mobile-first approach, Lotus Research emphasizes advanced technology, exceptional product design, and immersive user experiences to bring practical and entertaining solutions to market.
“Vu-Me (vu.me) is The Movie Studio “APP” that we have always envisioned and when completed, could accelerate The Movie Studio content and business model with a unique platform currently not implemented by any other independent motion picture Company and create unique value propositions for on-line subscribers aligning an APP for Theatrical Releases and subsequent VOD releases, would be a “Netflix for Movie Theaters” ideology with VOD on all your devices. Gordon Scott Venters, President and CEO stated today.
$MVES TIGHT SS, Major Catalysts Coming Soon.
134 MILLION FLOAT!!!!!!!!!!!!!!!
Near 52 week low
52-Wk Range
0.002 - 0.013
Price
$0.0023
Market Value1
$534,256
a/o Nov 10th, 2017
Authorized Shares
750,000,000
a/o Nov 1st, 2017
Outstanding Shares
378,609,979
a/o Nov 1st, 2017
-Restricted
243,987,853
-Unrestricted
Not Available
Held at DTC
Not Available
Float
134,622,126
a/o Nov 1st, 2017
HALLANDALE BEACH, Fla., Oct. 19, 2017 (GLOBE NEWSWIRE) -- The Movie Studio, Inc. (OTC:MVES) (the "Company") www.TheMovieStudio.com is a vertically integrated motion picture production and distribution company motion pictures, production and distribution assets.
The Movie Studio is pleased to announce that it has successfully negotiated a content license and revenue participation agreement with Lotus Research, Inc. for the Vu-Me on-line content aggregation and application platform. The Movie Studio and Vu-Me App Platform intend to implement an on-line platform and dashboard for “The Movie Studio” with a subscription based credit card interface to access The Movie Studio library and “New Releases” of owned and licensed content available for Video on Demand (VOD) to monetize the content including a back end “bank” In addition to the VOD Platform, The Movie Studio intends to integrate in the acquisition of Emerging Pictures and all of its assets, including its proprietary intellectual property, which includes an innovative technology for a Commercial VOD (Video on Demand) digital delivery platform presently deployed in over 130 theaters, as well as digital distribution rights to potentially many hundreds of films. The technology can also be used to gauge consumer demand as well as provide advanced data analytics to match and deliver content. This enables providers and exhibitors to be more effective and advanced in their distribution tactics and have greater direct contact and feedback from their audiences. The network of over 130 theaters in which the VOD hardware is presently deployed spans 36 states in the U.S.
“With many competing apps available to consumers, Lotus Research opted to leap ahead of the technology wave with several important features,” noted Leo Pimentel. These features include: (1) low latency across WiFi and cellular networks; (2) 4K and HD streaming and playback; (3) a proprietary compression algorithm; (4) rapid share-ability across social networking sites and communication channels; (5) machine-learning algorithms to refine and enhance search and content relevance; and (6) effective content tracking across all platforms on and off Vu-Me for robust and accurate reporting and metrics gathering. Leo Pimentel, CEO & Founder, stated today.
About Lotus Research, Inc.: Lotus Research is headquartered in New York City and was founded by Leo Pimentel in 2014. With a mobile-first approach, Lotus Research emphasizes advanced technology, exceptional product design, and immersive user experiences to bring practical and entertaining solutions to market.
“Vu-Me (vu.me) is The Movie Studio “APP” that we have always envisioned and when completed, could accelerate The Movie Studio content and business model with a unique platform currently not implemented by any other independent motion picture Company and create unique value propositions for on-line subscribers aligning an APP for Theatrical Releases and subsequent VOD releases, would be a “Netflix for Movie Theaters” ideology with VOD on all your devices. Gordon Scott Venters, President and CEO stated today.
Yes Pepsi.. Good people and great DD here. $INTK
Danielle isnt doing her job lol, I have emailed her twice. Thanks man for info. I will update.
You have link 2 SS info?
LOL I bought 13s last week.. Look at this guy <-----
Total shares authorized: 750,000,000; as of: July 2017.
Total share outstanding: 286,353,316; as of: July 2017.
Float of april all I can find. TA no help, email out 2 company
They should be filing an extension or quarterly here soon.
1. For each Fiscal Quarter End, upload a Quarterly Report via www.OTCIQ.com within 45 days of the quarter end. (A separate quarterly report is not required for the 4th quarter.) The Quarterly Report should include:
? Information in accordance with these OTC Pink Basic Disclosure Guidelines -- use the fillable form beginning on page 3.
? Quarterly financial statements (Balance Sheet, Income Statement, Statement of Cash Flows, Notes to Financial Statements).
? No Audit Letter or Attorney Letter is required.